Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Alkem Laboratories Limited

Capitalization 636B 6.89B 6B 5.44B 5.19B 9.44B 9.78B 64.6B 25.67B 304B 25.87B 25.32B 1,098B P/E ratio 2026 *
25.2x
P/E ratio 2027 * 27.8x
Enterprise value 608B 6.59B 5.74B 5.2B 4.96B 9.02B 9.35B 61.75B 24.54B 291B 24.73B 24.21B 1,050B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.7x
Free-Float
32.19%
Yield 2026 *
1%
Yield 2027 * 1%
1 day-0.61%
1 week-3.74%
Current month-5.61%
1 month-1.47%
3 months-5.36%
6 months-3.23%
Current year-3.33%
1 week 5,233
Extreme 5233
5,665
1 month 5,233
Extreme 5233
5,781.5
Current year 5,233
Extreme 5233
5,933.5
1 year 4,611.85
Extreme 4611.85
5,933.5
3 years 3,087.6
Extreme 3087.6
6,439.9
5 years 2,540.05
Extreme 2540.05
6,439.9
10 years 1,152.5
Extreme 1152.5
6,439.9
Manager TitleAgeSince
Chief Executive Officer - 21/09/2023
Director of Finance/CFO - 31/01/2024
Compliance Officer 56 31/10/2006
Director TitleAgeSince
Director/Board Member 43 08/08/2013
Director/Board Member 63 10/02/2008
Director/Board Member 44 10/11/2019
Change 5d. change 1-year change 3-years change Capi.($)
-0.61%-3.74%+13.09%+72.83% 6.92B
+0.15%-2.10%+19.69%+199.57% 880B
+0.49%+0.15%+49.20%+57.73% 582B
+0.91%-2.52%+3.38%+42.76% 388B
+0.50%-3.04%+3.60%+23.34% 324B
-0.11%-0.54%+20.67%+33.02% 295B
+0.07%-3.08%+23.16%+57.73% 293B
+0.39%-1.48%+21.72%+7.49% 286B
+0.27%-2.53%+15.85%+56.65% 197B
-0.12%-1.36%+28.84%+81.14% 180B
Average +0.20%-1.65%+19.92%+63.23% 343.31B
Weighted average by Cap. +0.32%-1.37%+22.12%+84.04%

Financials

2026 *2027 *
Net sales 146B 1.58B 1.38B 1.25B 1.19B 2.17B 2.25B 14.83B 5.89B 69.92B 5.94B 5.82B 252B 162B 1.76B 1.53B 1.38B 1.32B 2.4B 2.49B 16.45B 6.54B 77.55B 6.59B 6.45B 280B
Net income 25.12B 272M 237M 215M 205M 372M 386M 2.55B 1.01B 12.02B 1.02B 999M 43.34B 23.07B 250M 218M 197M 188M 342M 355M 2.34B 931M 11.04B 938M 918M 39.81B
Net Debt -28.13B -305M -265M -240M -229M -417M -432M -2.86B -1.13B -13.46B -1.14B -1.12B -48.54B -36.86B -399M -348M -315M -300M -546M -567M -3.74B -1.49B -17.64B -1.5B -1.47B -63.61B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.
Employees
18,785
Date Price Change Volume
16/03/26 5,323.00 -0.61% 204,293
13/03/26 5,355.50 -1.63% 103,318
12/03/26 5,444.00 -1.81% 121,868
11/03/26 5,544.50 -1.28% 147,779
10/03/26 5,616.50 +2.87% 127,594
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
5,323.00INR
Average target price
5,911.29INR
Spread / Average Target
+11.05%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW